Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Karoline J. Henanger"'
Autor:
Marianne Nordlund Broughton, Arne Westgaard, Elisabeth Paus, Miriam Øijordsbakken, Karoline J Henanger, Bjørn Naume, Trine Bjøro
Publikováno v:
Tumor Biology, Vol 39 (2017)
The use of trastuzumab in patients with breast cancer that overexpresses human epidermal growth factor receptor 2 has significantly improved treatment outcomes. However, a substantial proportion of this patient group still experiences progression of
Externí odkaz:
https://doaj.org/article/5ad1681569454616bca7e93f812e807a
Autor:
Pawel Mielnik, Jørgen Jahnsen, Ingvild S H Hatten, Cecilia Vold, Maud-Kristine A Ljoså, Ulf Prestegård, Jon Florholmen, Magne Henriksen, Bjørn Gulbrandsen, G. L. Goll, Kåre S Tveit, Ingrid Prytz Berset, Ingrid M. Blomgren, Hilde Stray, Julia R Kruse, Sigrun K Sæther, Inger M Hansen, Somyeh Baigh, Katrine Dvergsnes, Kenneth Waksvik, C. Mørk, Bjørg Ts Fevang, Clara Gram Gjesdal, Gert Huppertz-Hauss, Inge C. Olsen, Nils J Mørk, Sunniva S Hoie, Jon Hagfors, Jan Henrik Rydning, Tore K Kvien, Kristine Skjetne, Njaal Stray, Kristin Ryggen, Synøve Kalstad, M. Lorentzen, David J. Warren, Geir Noraberg, Berit H J Grandaunet, Roald Torp, Bjørn Moum, Karoline J. Henanger, Armin Poyan, Svein Oskar Frigstad, E. K. Strand, Espen A Haavardsholm, Knut E.A. Lundin, K. K. Jørgensen, Camilla C Zettel, Jan Krogh, Irina P Midtgard, Øivind Asak, Trude J Bruun, Nils Bolstad, Haroon U Rashid, Kathrine A. Seeberg, Liv Sagatun, Carl Magnus Ystrøm
Publikováno v:
The Lancet. 389:2304-2316
Summary Background TNF inhibitors have improved treatment of Crohn's disease, ulcerative colitis, spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis, but are expensive therapies. The aim of NOR-SWITCH was to ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8cbbaec9dc7fa5b87aea27da7ee6159
https://doi.org/10.1016/s0140-6736(17)30068-5
https://doi.org/10.1016/s0140-6736(17)30068-5
Autor:
Arne Westgaard, Elisabeth Paus, Miriam Øijordsbakken, Marianne Nordlund Broughton, Karoline J Henanger, Bjørn Naume, Trine Bjøro
Publikováno v:
Tumor Biology, Vol 39 (2017)
The use of trastuzumab in patients with breast cancer that overexpresses human epidermal growth factor receptor 2 has significantly improved treatment outcomes. However, a substantial proportion of this patient group still experiences progression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8622acfe16f88f6b8e91adc35ae86b44
https://doaj.org/article/5ad1681569454616bca7e93f812e807a
https://doaj.org/article/5ad1681569454616bca7e93f812e807a